• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Immunopathologic mechanisms of dengue hemorrhagic fever and dengue shock syndrome.

作者信息

Kurane I, Rothman A L, Livingston P G, Green S, Gagnon S J, Janus J, Innis B L, Nimmannitya S, Nisalak A, Ennis F A

机构信息

Department of Medicine, University of Massachusetts Medical Center, Worcester.

出版信息

Arch Virol Suppl. 1994;9:59-64. doi: 10.1007/978-3-7091-9326-6_7.

DOI:10.1007/978-3-7091-9326-6_7
PMID:8032282
Abstract

Dengue virus infections are a major cause of morbidity and mortality in tropical and subtropical areas of the world. The immunopathological mechanisms that result in severe complications of dengue virus infection, i.e. dengue hemorrhagic fever (DHF), are important to determine. Primary dengue virus infections induce serotype-specific and serotype-cross-reactive, CD4+ and CD8+ memory cytotoxic T lymphocytes (CTL). In secondary infections with a virus of a different serotype from that which caused primary infections, the presence of cross-reactive non-neutralizing antibodies results in an increased number of infected monocytes by dengue virus--antibody complexes. This in turn results in marked activation of serotype cross-reactive CD4+ and CD8+ memory CTL. We hypothesize that the rapid release of cytokines and chemical mediators caused by T cell activation and by CTL-mediated lysis of dengue virus-infected monocytes triggers the plasma leakage and hemorrhage that occurs in DHF.

摘要

相似文献

1
Immunopathologic mechanisms of dengue hemorrhagic fever and dengue shock syndrome.
Arch Virol Suppl. 1994;9:59-64. doi: 10.1007/978-3-7091-9326-6_7.
2
Dengue virus-specific human T cell clones. Serotype crossreactive proliferation, interferon gamma production, and cytotoxic activity.登革病毒特异性人类T细胞克隆。血清型交叉反应性增殖、γ干扰素产生及细胞毒性活性。
J Exp Med. 1989 Sep 1;170(3):763-75. doi: 10.1084/jem.170.3.763.
3
Human immune responses to dengue viruses.人类对登革病毒的免疫反应。
Southeast Asian J Trop Med Public Health. 1990 Dec;21(4):658-62.
4
Dominant recognition by human CD8+ cytotoxic T lymphocytes of dengue virus nonstructural proteins NS3 and NS1.2a.人类CD8 + 细胞毒性T淋巴细胞对登革病毒非结构蛋白NS3和NS1.2a的主要识别
J Clin Invest. 1996 Oct 1;98(7):1684-91. doi: 10.1172/JCI118964.
5
Immunity and immunopathology in dengue virus infections.登革病毒感染中的免疫与免疫病理学
Semin Immunol. 1992 Apr;4(2):121-7.
6
High pro-inflammatory cytokine secretion and loss of high avidity cross-reactive cytotoxic T-cells during the course of secondary dengue virus infection.在二次登革病毒感染过程中促炎细胞因子的高分泌及高亲和力交叉反应性细胞毒性T细胞的丧失。
PLoS One. 2007 Dec 5;2(12):e1192. doi: 10.1371/journal.pone.0001192.
7
Dengue hemorrhagic fever with special emphasis on immunopathogenesis.登革出血热,特别强调免疫发病机制。
Comp Immunol Microbiol Infect Dis. 2007 Sep;30(5-6):329-40. doi: 10.1016/j.cimid.2007.05.010. Epub 2007 Jul 23.
8
Role of T cells, cytokines and antibody in dengue fever and dengue haemorrhagic fever.T细胞、细胞因子和抗体在登革热及登革出血热中的作用。
Rev Med Virol. 2006 Jul-Aug;16(4):263-75. doi: 10.1002/rmv.507.
9
Dengue virus-specific, HLA-B35-restricted, human CD8+ cytotoxic T lymphocyte (CTL) clones. Recognition of NS3 amino acids 500 to 508 by CTL clones of two different serotype specificities.登革病毒特异性、HLA - B35限制的人类CD8 + 细胞毒性T淋巴细胞(CTL)克隆。两种不同血清型特异性的CTL克隆对NS3氨基酸500至508的识别。
J Immunol. 1995 Feb 1;154(3):1287-95.
10
The pathology of dengue hemorrhagic fever.登革出血热的病理学
Semin Diagn Pathol. 2007 Nov;24(4):227-36. doi: 10.1053/j.semdp.2007.07.002.

引用本文的文献

1
A Cluster of Dengue Cases in Travelers: A Clinical Series from Thailand.旅行者中的登革热病例群:来自泰国的临床系列报道
Trop Med Infect Dis. 2021 Aug 14;6(3):152. doi: 10.3390/tropicalmed6030152.
2
Use of Animal Models in Studying Roles of Antibodies and Their Secretion Cells in Dengue Vaccine Development.在研究抗体及其分泌细胞在登革热疫苗开发中的作用的过程中使用动物模型。
Viruses. 2020 Nov 5;12(11):1261. doi: 10.3390/v12111261.
3
Considering Genomic and Immunological Correlates of Protection for a Dengue Intervention.考虑登革热干预措施的基因组和免疫相关保护因素。
Vaccines (Basel). 2019 Dec 3;7(4):203. doi: 10.3390/vaccines7040203.
4
Association of Allergic Symptoms with Dengue Infection and Severity: A Systematic Review and Meta-analysis.过敏性症状与登革热感染和严重程度的关联:系统评价和荟萃分析。
Virol Sin. 2020 Feb;35(1):83-92. doi: 10.1007/s12250-019-00165-6. Epub 2019 Oct 21.
5
The Good, the Bad, and the Shocking: The Multiple Roles of Dengue Virus Nonstructural Protein 1 in Protection and Pathogenesis.好、坏、惊:登革病毒非结构蛋白 1 在保护和发病机制中的多重作用。
Annu Rev Virol. 2018 Sep 29;5(1):227-253. doi: 10.1146/annurev-virology-101416-041848. Epub 2018 Jul 25.
6
Use of optical coherence tomography to evaluate visual acuity and visual field changes in dengue fever.使用光学相干断层扫描评估登革热患者的视力和视野变化。
Korean J Ophthalmol. 2014 Feb;28(1):96-9. doi: 10.3341/kjo.2014.28.1.96. Epub 2014 Jan 21.
7
Distinct activation phenotype of a highly conserved novel HLA-B57-restricted epitope during dengue virus infection.登革病毒感染过程中高度保守的新型 HLA-B57 限制性表位的独特激活表型。
Immunology. 2014 Jan;141(1):27-38. doi: 10.1111/imm.12161.
8
RNA interference mediated inhibition of dengue virus multiplication and entry in HepG2 cells.RNA 干扰介导的登革热病毒在 HepG2 细胞中的增殖和进入抑制。
PLoS One. 2012;7(3):e34060. doi: 10.1371/journal.pone.0034060. Epub 2012 Mar 23.
9
Rapid and massive virus-specific plasmablast responses during acute dengue virus infection in humans.在人类急性登革热病毒感染期间,快速且大量的病毒特异性浆母细胞反应。
J Virol. 2012 Mar;86(6):2911-8. doi: 10.1128/JVI.06075-11. Epub 2012 Jan 11.
10
Dengue hemorrhagic fever-associated immunomediators induced via maturation of dengue virus nonstructural 4B protein in monocytes modulate endothelial cell adhesion molecules and human microvascular endothelial cells permeability.登革出血热相关免疫介质通过单核细胞中登革病毒非结构蛋白 4B 的成熟诱导,调节内皮细胞黏附分子和人微血管内皮细胞通透性。
Virology. 2012 Jan 20;422(2):326-37. doi: 10.1016/j.virol.2011.10.030. Epub 2011 Nov 29.